Cheng, Rene Yu-Hong
Hung, King L. http://orcid.org/0000-0002-3662-4662
Zhang, Tingting
Stoffers, Claire M.
Ott, Andee R.
Suchland, Emmaline R.
Camp, Nathan D. http://orcid.org/0000-0002-1216-5262
Khan, Iram F.
Singh, Swati
Yang, Ying-Jen http://orcid.org/0000-0002-2559-2773
Rawlings, David J. http://orcid.org/0000-0002-0810-1776
James, Richard G. http://orcid.org/0000-0002-2302-7367
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (5R01CA201135)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI140626)
Article History
Received: 13 October 2021
Accepted: 4 October 2022
First Online: 16 October 2022
Competing interests
: A patent application has been filed (K.L.H., I.F.K., D.J.R., and R.G.J. “Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins,” US patent application no. US20180282692A1). The remaining authors declare no competing interests.